Diurnal variations in serum and urine markers of type I and type III collagen turnover in children.

References 1. Green B. Focus on olanzapine. Curr Med Res Opin 1999;15:79–85. 2. Perry JP, Sanger T, Beasley C. Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients. J Clin Psychopharmacol 1997;17:442–77. 3. Aravagiri M, Ames D, Wirshing WC, Marder SR. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection. Ther Drug Monit 1997;19:307–13. 4. Robertson MD, McMullin MM. Olanzapine concentrations in clinical serum and postmortem blood specimens-when does therapeutic become toxic? J Forensic Sci 2000;45:418–21. 5. Smith RM, Westlake JP, Gill R, Osselton MD. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-high pH buffer eluent. J Chromatogr 1992;592:85–92. 6. Olesen OV, Linnet K. Determination of olanzapine in serum by highperformance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs. J Chromatogr B Biomed Sci Appl 1998;714:309–15. 7. Catlow JT, Barton RD, Clemens M, Gillespie TA, Goodwin M, Swanson SP. Analysis of olanzapine in human plasma utilizing reversed-phase highperformance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 1995;668:85–90. 8. Chiu JA, Franklin RB. Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection. J Pharm Biomed Anal 1996;14:609–15. 9. Berna M, Shugert R, Mullen J. Determination of olanzapine in human plasma and serum by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 1998;33:1003–8. 10. Coudore F, Ardid D, Eschalier A, Fialip J, Lavarenne J. High-performance liquid chromatographic determination of amitriptyline and its main metabolites using a silica column with reversed-phase eluent. Application in mice. J Chromatogr 1992;584:249–55. 11. Coudore F, Hourcade F, Molinier-Manoukian C, Eschalier A, Lavarenne J. Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites. J Anal Toxicol 1996;20:101–5. 12. Coudore F, Nicolay A, Hoareau M, Eschalier A. Another use of silica gel and aqueous eluent for HPLC analysis of clozapine and desmethylclozapine. J Anal Toxicol 1999;23:195–9. 13. Kurz M, Hummer M, Kemmler G, Kurzthaler I, Saria A, Fleischhacker WW. Long-term pharmacokinetics of clozapine. Br J Psychiatry 1998;173:341–4.